Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

BPC-157 and VIP Interaction: Compatible | Peptide Database

Can you take BPC-157 with VIP? Compatible interaction (90% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

VIP

Vasoactive Intestinal Peptide | Neuropeptide

VIP binds to VPAC1 and VPAC2 G protein-coupled receptors, activating adenylyl cyclase and increasing intracellular cAMP and PKA activity. This triggers phosphorylation of CREB and other transcription factors.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take BPC-157 with VIP?

Yes, BPC-157 and VIP can generally be taken together. No known negative interactions; different mechanisms.

Is BPC-157 and VIP safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and VIP?

No known negative interactions; different mechanisms. This assessment has 90% confidence and is based on documented research data.

How should I time BPC-157 and VIP?

BPC-157 has a half-life of <30 minutes and VIP has a half-life of 1-2 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question